Atlas Venture Fund Xi, L.P. is of Third Harmonic Bio, Inc.. Currently has a direct ownership of 9.8 Million shares of THRD, which is worth approximately $106 Million. The most recent transaction as insider was on Nov 01, 2024, when has been sold 515,688 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.8M
1549.24% 3M change
1549.24% 12M change
Total Value Held $106 Million

Atlas Venture Fund XI, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2024
SELL
Other acquisition or disposition
-
515,688 Reduced 5.0%
9,798,075 Common Stock
Sep 19 2022
BUY
Open market or private purchase
$5,100,000 $17.0 p/Share
300,000 Added 2.83%
10,313,763 Common Stock
Sep 19 2022
BUY
Conversion of derivative security
-
7,066,470 Added 92.24%
594,096 Common Stock

Also insider at

DAWN
Day One Biopharmaceuticals, Inc. Healthcare
DYN
Dyne Therapeutics, Inc. Healthcare
XLO
Xilio Therapeutics, Inc. Healthcare
IKNA
Ikena Oncology, Inc. Healthcare
AVF

Atlas Venture Fund Xi, L.P.

Cambridge, MA

Track Institutional and Insider Activities on THRD

Follow Third Harmonic Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells THRD shares.

Notify only if

Insider Trading

Get notified when an Third Harmonic Bio, Inc. insider buys or sells THRD shares.

Notify only if

News

Receive news related to Third Harmonic Bio, Inc.

Track Activities on THRD